Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00670644 · ClinicalTrials.gov registry record
Self-Care for Lymphedema in Patients With Breast Cancer
A clinical trial, sponsored by Vanderbilt University.
- Completed
- Registry status
- 51
- Enrollment target
NCT00670644: Completed study, sponsored by Vanderbilt University.
NCT00670644 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00670644 has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
RATIONALE: Identifying why patients don't do self care for lymphedema may help doctors plan better at-home self-care treatment. PURPOSE: This research study is looking at self-care practices for lymphedema in patients with breast cancer.
Interventions
- OTHER questionnaire administration
- OTHER survey administration
- PROCEDURE quality-of-life assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2006-05 |
| Est. Completion | 2011-03 |
What the finished NCT00670644 record still lists
NCT00670644 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which questionnaire administration is the first listed.
NCT00670644 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00670644 about?
NCT00670644 is a clinical study titled "Self-Care for Lymphedema in Patients With Breast Cancer". RATIONALE: Identifying why patients don't do self care for lymphedema may help doctors plan better at-home self-care treatment. PURPOSE: This research study is looking at self-care practices for lymphedema in patients with breast cancer.
What is the current status of trial NCT00670644?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2006-05. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00670644?
The interventions under investigation include: questionnaire administration (OTHER), survey administration (OTHER), quality-of-life assessment (PROCEDURE).
Who is sponsoring clinical trial NCT00670644?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia